This is achieved, at least in part, by its association with enzymes, such as paraoxonase-1 (PON-1), which serves to hydrolyse oxidised lipids [18] and whose activity is inversely correlated with the risk and severity of CAD in T2DM patients [64]. The gene discussed is PON1; the disease is coronary artery disorder.